ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market
Holding IMUC?
Track your performance easily

ImmunoCellular Therapeutics (IMUC) Income Statement

180 Followers

ImmunoCellular Therapeutics Income Statement

Last quarter (Q2 2018), ImmunoCellular Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, ImmunoCellular Therapeutics's net income was $-306.70K. See ImmunoCellular Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 17Dec 16Dec 15Dec 14Dec 13
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
----$ 0.00$ 0.00
Gross Profit
----$ 0.00$ 0.00
Operating Expense
$ 5.66M$ 21.15M$ 24.11M$ 15.51M$ 9.86M$ 9.46M
Operating Income
$ -5.66M$ -21.15M$ -24.11M$ -15.51M$ -9.86M$ -9.46M
Net Non Operating Interest Income Expense
$ 1.11K$ -878.00K$ -1.79M$ -202.98K$ -48.77K$ 17.34K
Other Income Expense
-$ 7.72M$ 3.81M$ 2.93M$ 529.77K$ 642.41K
Pretax Income
$ -5.66M$ -14.31M$ -22.09M$ -12.79M$ -9.38M$ -8.80M
Tax Provision
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -9.03M$ -17.68M$ -22.09M$ -12.79M$ -9.38M$ -8.80M
Basic EPS
$ -4.69$ -12.30$ -78.90$ -60.00$ -64.00$ -64.00
Diluted EPS
$ -4.73$ -12.30$ -78.91$ -60.00$ -64.00$ -64.00
Basic Average Shares
$ 14.11M$ 1.44M$ 279.89K$ 218.01K$ 149.79K$ 135.70K
Diluted Average Shares
$ 14.11M$ 1.44M$ 279.89K$ 218.01K$ 149.79K$ 135.70K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 5.66M$ 21.15M$ 24.11M$ 15.51M$ 9.86M$ 9.46M
Net Income From Continuing And Discontinued Operation
$ -5.66M$ -14.31M$ -22.09M$ -12.79M$ -9.38M$ -8.80M
Normalized Income
$ -5.66M$ -14.31M$ -25.90M$ -15.72M$ -9.91M$ -9.44M
Interest Expense
-$ 882.68K$ 1.31M$ 133.91K$ 0.00$ 0.00
EBIT
$ -5.66M$ -13.43M$ -20.77M$ -12.66M$ -9.38M$ -9.46M
EBITDA
$ -5.65M$ -13.38M$ -20.70M$ -12.62M$ -9.33M$ -9.41M
Currency in USD

ImmunoCellular Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis